Verschraagen Miranda, Maes Ann, Ruiter Bart, Bosman Ingrid J, Smink Beitske E, Lusthof Klaas J
Netherlands Forensic Institute, Department of Toxicology, The Hague, The Netherlands.
Forensic Sci Int. 2007 Aug 6;170(2-3):163-70. doi: 10.1016/j.forsciint.2007.03.030. Epub 2007 Jul 20.
In this study we reviewed the post-mortem cases in the years 1999-2004 that were presented at the Netherlands Forensic Institute. The concentrations of amphetamine-based drugs in femoral blood from cases of suspected unnatural death were compared with concentrations in whole blood from non-fatal cases of driving under the influence (DUI cases) and with literature. Furthermore, the combinations with other drugs and/or alcohol were investigated. Amphetamine-based drugs were present in 70 post-mortem cases and 467 DUI cases. The most detected amphetamine-based drug was MDMA, followed by amphetamine. The presence of MDA could usually be explained by metabolism of MDMA. Methamphetamine and MDEA were rarely present. Frequently, the amphetamine-based drugs were taken in combination with alcohol and/or other non-amphetamine-based drugs such as cocaine or cannabinoids. The 70 post-mortem cases were divided into 38 amphetamine-based drug caused (i.e. the amphetamine-based drug directly caused or contributed to the death) and 32 amphetamine-based drug related deaths (i.e. death was not directly caused by the amphetamine-based drug). In the latter category, other (poly)drug intoxications and death by violence or drowning were the most frequent causes of death. In 30 cases, MDMA caused death directly. The range in blood concentrations of MDMA in these cases was substantial, i.e. 0.41-84 mg/L with a median concentration of 3.7 mg/L (n=30). MDMA blood concentrations in the MDMA related deaths (n=20) and in the DUI cases (n=360) varied up to 3.7 and 4.0 mg/L, respectively. Seven victims died from the direct effects of amphetamine; the blood concentration of amphetamine ranged from 0.24 to 11.3 mg/L, with a median concentration of 1.7 mg/L (n=7). The median concentrations of amphetamine in the amphetamine related deaths (n=13) and the DUI cases (n=208) were much lower, i.e. 0.28 and 0.22 mg/L, respectively. Amphetamine blood concentrations up to 6.0 and 2.3 mg/L were seen in the drug related deaths and DUI cases, respectively. The most frequently encountered amphetamine-based drugs in the investigated deaths were MDMA and amphetamine. The majority of MDMA- and amphetamine-caused deaths, i.e. 90% of these deaths, occurred with blood concentrations above 1.5 and 0.80 mg/L, respectively. MDMA and amphetamine blood concentrations in drug related deaths and DUI cases, however, overlap the range of fatal concentrations. Therefore, MDMA or amphetamine concentrations should never be used alone to establish the cause of death.
在本研究中,我们回顾了1999年至2004年间提交至荷兰法医学研究所的尸检案例。将疑似非自然死亡案例股动脉血中苯丙胺类药物的浓度与非致命性酒后驾车案例(酒后驾车案例)全血中的浓度以及文献中的浓度进行了比较。此外,还研究了与其他药物和/或酒精的联用情况。在70例尸检案例和467例酒后驾车案例中检测到了苯丙胺类药物。检测到最多的苯丙胺类药物是摇头丸,其次是苯丙胺。甲基苯丙胺的存在通常可由摇头丸的代谢来解释。甲基安非他命和3,4-亚甲基二氧-N-乙基苯丙胺很少出现。通常,苯丙胺类药物与酒精和/或其他非苯丙胺类药物如可卡因或大麻素联用。这70例尸检案例分为38例由苯丙胺类药物导致的死亡(即苯丙胺类药物直接导致或促成死亡)和32例与苯丙胺类药物相关的死亡(即死亡并非直接由苯丙胺类药物导致)。在后一类中,其他(多种)药物中毒以及暴力或溺水死亡是最常见的死因。在30例案例中,摇头丸直接导致了死亡。这些案例中摇头丸的血药浓度范围很大,即0.41 - 84毫克/升,中位数浓度为3.7毫克/升(n = 30)。与摇头丸相关的死亡案例(n = 20)和酒后驾车案例(n = 360)中摇头丸的血药浓度分别高达3.7毫克/升和4.0毫克/升。7名受害者死于苯丙胺的直接作用;苯丙胺的血药浓度范围为0.24至11.3毫克/升,中位数浓度为1.7毫克/升(n = 7)。与苯丙胺相关的死亡案例(n = 13)和酒后驾车案例(n = 208)中苯丙胺的中位数浓度要低得多,分别为0.28毫克/升和0.22毫克/升。在与药物相关的死亡案例和酒后驾车案例中,苯丙胺的血药浓度分别高达6.0毫克/升和2.3毫克/升。在所调查的死亡案例中,最常遇到的苯丙胺类药物是摇头丸和苯丙胺。在大多数由摇头丸和苯丙胺导致的死亡案例中,即这些死亡案例的90%,发生时的血药浓度分别高于1.5毫克/升和0.80毫克/升。然而,与药物相关的死亡案例和酒后驾车案例中摇头丸和苯丙胺的血药浓度与致命浓度范围有重叠。因此,绝不应单独使用摇头丸或苯丙胺的浓度来确定死因。